Department of Medicine

Division of Hematology and Oncology

John W. Hiemenz, MD Clinical Professor Division of Hematology / Oncology University of Florida 1600 SW Archer Road/Box 100277 Gainesville, FL  32610-0277 (352) 273-7832/FAX (352) 273-5006

John W. Hiemenz, M.D. is a board certified medical oncologist trained in adult and pediatric oncology, as well as infectious diseases, who has special interest and expertise in  the care and management of patients with hematological malignancies and those undergoing hematopoietic stem cell transplantation.  After his initial recruitment to join the bone marrow transplant faculty at UF in Gainesville as an assistant professor, Dr. Hiemenz moved to Tampa to help establish the newly formed Division of Bone Marrow Transplantation at the H. Lee Moffitt Cancer Center under the leadership of its founding director, Dr. Gerald Elfenbein (another former UF faculty member).  His subsequent academic appointments have included Professor and Co-Director of the Blood and Marrow Transplant Program at the Medical College of Georgia, and most recently Professor, and Director, Hematological Malignancies and BMT Program as well as Head, Infectious Diseases Research Program at the Feist-Weiller Cancer Center, LSU Health Sciences Center in Shreveport, Louisiana.  Dr. Hiemenz has recently returned to Gainesville and rejoins the faculty as Clinical Professor of Medicine to assist in the continued growth of the University of Florida/Shands Bone Marrow Transplant and Leukemia Program.   

Training:

Clinical Interests/Academic Interests:

Dr. Hiemenz’ clinical and academic interests include the diagnosis and treatment of hematological malignancies and primary bone marrow disorders, the use of hematopoietic stem cell transplantation for the treatment of malignant and non-malignant diseases, and  supportive care for the patient undergoing intensive induction therapy and/or hematopoietic stem cell transplantation with particular interest in the diagnosis and management of graft versus host disease and infectious complications in the immune compromised host.  

Representative Publications:

• Hiemenz JW. Management of infections complicating allogeneic hematopoietic stem cell transplantation. Seminars in Hematology 2009; 46: 289-312.
• Gumbo T, Hiemenz J, Ma L, Keirns JJ, Buell DN, Drusano GL. Population pharmacokinetics of micafungin in adult patients. Diag Microbiol Infect Dis. 2008; 60: 329-31.
• Chintapalli N, Lowery-Nordberg, M, Hiemenz J, Turturro F. Acute myeloid leukemia disguised as a solid tumor. Clin Leukemia 2007; 1:198-200.
• Hiemenz J, Cagnoni P, Simpson D, Devine S, Choa N, Keirns J, Lau W, Facklam D, Buell D. Pharmacokinetic and  maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.  Antimicrob Agents Chemother. 2005; 49:1331-6.
• van Burik JH, Ranathanatharathorn V, Stephan DE, Miller CB, Lipton J, Vesole DH, Bunin N, Wall DA, Hiemenz J, Satori Y, Lee JM, and Walsh TJ for the NIAID Mycosis Study Group: Micafungin versus fluconazole for prophylaxis of invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis. 2004; 39:1407-16.
• Ballester OF, Fang T, Raptis A, Ballester G, Willcox P, Hiemenz J, Tan B. Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma. Bone Marrow Transplant. 2004; 34: 419-23.
• Hiemenz JW, Groll AH, Walsh TJ. Infections caused by rare fungi fungi after hematopoietic stem cell or solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV, eds. Transplant Infections, 2nd ed. Philadephia: Lippincott Williams & Wilkins; 2003, p. 509-523.